Tobin Schilke

CRNX

Tobin Schilke serves as officer: Chief Financial Officer at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$532.6K

Net Position

Net Seller

$532.6K

Companies Traded

CRNX

Active Period

Mar 2026

1 total trades

Most Recent

Sell CRNX

Mar 4, 2026 · $532.6K

Tobin Schilke's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

1 · $532.6K

Total Shares Bought

Total Shares Sold

13,426

CRNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 4, 2026↗	Sell	13,426	$39.67	$532.6K	78,121

Related Insiders

Stephanie Okey

director

CRNXSell · Mar 3, 2026

Isabel Kalofonos

Chief Commercial Officer

CRNXSell · Jan 5, 2026

Isabel Kalofonos

officer: Chief Commercial Officer

CRNXSell · Jan 5, 2026

Dana Pizzuti

Chief Med and Dev Officer

CRNXSell · Dec 1, 2025

Matthew K Fust

Director

CRNXSell · Sep 26, 2025

Richard Scott Struthers

President & CEO

CRNXSell · Sep 26, 2025

Stephen F. Betz

Chief Scientific Officer

CRNXSell · Jun 12, 2025

Jeff E. Knight

Chief Operating Officer

CRNXSell · Mar 19, 2025

Explore More Insider Trading Data

CRNX Insider Trading Activity

View all insider trades at Crinetics Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity